nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Sevoflurane—CYP2A6—prostate cancer	0.00683	0.464	CrCbGaD
Perflutren—Sevoflurane—CYP2E1—prostate cancer	0.00485	0.329	CrCbGaD
Perflutren—Sevoflurane—CYP3A4—prostate cancer	0.00305	0.207	CrCbGaD
Perflutren—Headache—Estradiol—prostate cancer	0.000326	0.000331	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—prostate cancer	0.000326	0.000331	CcSEcCtD
Perflutren—Agitation—Prednisone—prostate cancer	0.000326	0.000331	CcSEcCtD
Perflutren—Oedema—Capecitabine—prostate cancer	0.000325	0.00033	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—prostate cancer	0.000324	0.000329	CcSEcCtD
Perflutren—Angioedema—Prednisone—prostate cancer	0.000324	0.000329	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000322	0.000327	CcSEcCtD
Perflutren—Urticaria—Etoposide—prostate cancer	0.000321	0.000326	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—prostate cancer	0.00032	0.000325	CcSEcCtD
Perflutren—Malaise—Prednisone—prostate cancer	0.00032	0.000325	CcSEcCtD
Perflutren—Shock—Capecitabine—prostate cancer	0.00032	0.000324	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—prostate cancer	0.000319	0.000324	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—prostate cancer	0.000319	0.000324	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—prostate cancer	0.000319	0.000324	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—prostate cancer	0.000319	0.000324	CcSEcCtD
Perflutren—Nervous system disorder—Capecitabine—prostate cancer	0.000319	0.000323	CcSEcCtD
Perflutren—Vertigo—Prednisone—prostate cancer	0.000319	0.000323	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—prostate cancer	0.000319	0.000323	CcSEcCtD
Perflutren—Syncope—Prednisone—prostate cancer	0.000318	0.000323	CcSEcCtD
Perflutren—Tachycardia—Capecitabine—prostate cancer	0.000317	0.000322	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—prostate cancer	0.000317	0.000322	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—prostate cancer	0.000316	0.000321	CcSEcCtD
Perflutren—Skin disorder—Capecitabine—prostate cancer	0.000316	0.00032	CcSEcCtD
Perflutren—Hyperhidrosis—Capecitabine—prostate cancer	0.000314	0.000319	CcSEcCtD
Perflutren—Hypotension—Docetaxel—prostate cancer	0.000314	0.000318	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—prostate cancer	0.000313	0.000318	CcSEcCtD
Perflutren—Loss of consciousness—Prednisone—prostate cancer	0.000312	0.000316	CcSEcCtD
Perflutren—Nausea—Estradiol—prostate cancer	0.00031	0.000314	CcSEcCtD
Perflutren—Vomiting—Mitoxantrone—prostate cancer	0.000309	0.000313	CcSEcCtD
Perflutren—Convulsion—Prednisone—prostate cancer	0.000307	0.000312	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—prostate cancer	0.000307	0.000312	CcSEcCtD
Perflutren—Hypertension—Prednisone—prostate cancer	0.000306	0.000311	CcSEcCtD
Perflutren—Rash—Mitoxantrone—prostate cancer	0.000306	0.000311	CcSEcCtD
Perflutren—Dermatitis—Mitoxantrone—prostate cancer	0.000306	0.00031	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000306	0.00031	CcSEcCtD
Perflutren—Headache—Mitoxantrone—prostate cancer	0.000304	0.000309	CcSEcCtD
Perflutren—Hypotension—Capecitabine—prostate cancer	0.000304	0.000308	CcSEcCtD
Perflutren—Myalgia—Prednisone—prostate cancer	0.000302	0.000306	CcSEcCtD
Perflutren—Arthralgia—Prednisone—prostate cancer	0.000302	0.000306	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—prostate cancer	0.000301	0.000306	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—prostate cancer	0.0003	0.000305	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.0003	0.000304	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—prostate cancer	0.000299	0.000304	CcSEcCtD
Perflutren—Discomfort—Prednisone—prostate cancer	0.000298	0.000303	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—prostate cancer	0.000298	0.000302	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—prostate cancer	0.000298	0.000302	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—prostate cancer	0.000297	0.000302	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—prostate cancer	0.000296	0.000301	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000296	0.0003	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—prostate cancer	0.000296	0.0003	CcSEcCtD
Perflutren—Flushing—Epirubicin—prostate cancer	0.000296	0.0003	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—prostate cancer	0.000296	0.0003	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—prostate cancer	0.000295	0.0003	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—prostate cancer	0.000295	0.000299	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—prostate cancer	0.000293	0.000298	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—prostate cancer	0.000293	0.000297	CcSEcCtD
Perflutren—Paraesthesia—Capecitabine—prostate cancer	0.000292	0.000296	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00029	0.000294	CcSEcCtD
Perflutren—Asthenia—Etoposide—prostate cancer	0.00029	0.000294	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—prostate cancer	0.00029	0.000294	CcSEcCtD
Perflutren—Dyspnoea—Capecitabine—prostate cancer	0.00029	0.000294	CcSEcCtD
Perflutren—Oedema—Prednisone—prostate cancer	0.000289	0.000294	CcSEcCtD
Perflutren—Anaphylactic shock—Prednisone—prostate cancer	0.000289	0.000294	CcSEcCtD
Perflutren—Fatigue—Docetaxel—prostate cancer	0.000289	0.000294	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—prostate cancer	0.000289	0.000293	CcSEcCtD
Perflutren—Nausea—Mitoxantrone—prostate cancer	0.000288	0.000293	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—prostate cancer	0.000288	0.000292	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—prostate cancer	0.000287	0.000291	CcSEcCtD
Perflutren—Pain—Docetaxel—prostate cancer	0.000287	0.000291	CcSEcCtD
Perflutren—Dyspepsia—Capecitabine—prostate cancer	0.000286	0.00029	CcSEcCtD
Perflutren—Chills—Epirubicin—prostate cancer	0.000286	0.00029	CcSEcCtD
Perflutren—Pruritus—Etoposide—prostate cancer	0.000286	0.00029	CcSEcCtD
Perflutren—Shock—Prednisone—prostate cancer	0.000285	0.000289	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—prostate cancer	0.000285	0.000289	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—prostate cancer	0.000284	0.000288	CcSEcCtD
Perflutren—Nervous system disorder—Prednisone—prostate cancer	0.000284	0.000288	CcSEcCtD
Perflutren—Tachycardia—Prednisone—prostate cancer	0.000283	0.000287	CcSEcCtD
Perflutren—Skin disorder—Prednisone—prostate cancer	0.000281	0.000285	CcSEcCtD
Perflutren—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000281	0.000285	CcSEcCtD
Perflutren—Fatigue—Capecitabine—prostate cancer	0.00028	0.000284	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisone—prostate cancer	0.00028	0.000284	CcSEcCtD
Perflutren—Pain—Capecitabine—prostate cancer	0.000278	0.000282	CcSEcCtD
Perflutren—Erythema—Epirubicin—prostate cancer	0.000277	0.000282	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—prostate cancer	0.000277	0.000281	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—prostate cancer	0.000276	0.00028	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—prostate cancer	0.000276	0.00028	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—prostate cancer	0.000275	0.000279	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—prostate cancer	0.000274	0.000279	CcSEcCtD
Perflutren—Flushing—Doxorubicin—prostate cancer	0.000274	0.000278	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—prostate cancer	0.000274	0.000278	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—prostate cancer	0.000272	0.000276	CcSEcCtD
Perflutren—Back pain—Epirubicin—prostate cancer	0.000268	0.000272	CcSEcCtD
Perflutren—Feeling abnormal—Capecitabine—prostate cancer	0.000268	0.000272	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—prostate cancer	0.000268	0.000272	CcSEcCtD
Perflutren—Dizziness—Etoposide—prostate cancer	0.000267	0.000271	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—prostate cancer	0.000267	0.000271	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—prostate cancer	0.000266	0.00027	CcSEcCtD
Perflutren—Gastrointestinal pain—Capecitabine—prostate cancer	0.000266	0.00027	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—prostate cancer	0.000266	0.00027	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—prostate cancer	0.000265	0.000269	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—prostate cancer	0.000265	0.000269	CcSEcCtD
Perflutren—Chills—Doxorubicin—prostate cancer	0.000265	0.000269	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000264	0.000268	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—prostate cancer	0.000263	0.000267	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—prostate cancer	0.000261	0.000265	CcSEcCtD
Perflutren—Paraesthesia—Prednisone—prostate cancer	0.00026	0.000264	CcSEcCtD
Perflutren—Urticaria—Capecitabine—prostate cancer	0.000258	0.000262	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—prostate cancer	0.000257	0.000261	CcSEcCtD
Perflutren—Body temperature increased—Capecitabine—prostate cancer	0.000257	0.000261	CcSEcCtD
Perflutren—Abdominal pain—Capecitabine—prostate cancer	0.000257	0.000261	CcSEcCtD
Perflutren—Vomiting—Etoposide—prostate cancer	0.000257	0.000261	CcSEcCtD
Perflutren—Erythema—Doxorubicin—prostate cancer	0.000257	0.000261	CcSEcCtD
Perflutren—Agitation—Epirubicin—prostate cancer	0.000255	0.000259	CcSEcCtD
Perflutren—Dyspepsia—Prednisone—prostate cancer	0.000255	0.000259	CcSEcCtD
Perflutren—Rash—Etoposide—prostate cancer	0.000255	0.000258	CcSEcCtD
Perflutren—Dermatitis—Etoposide—prostate cancer	0.000254	0.000258	CcSEcCtD
Perflutren—Headache—Etoposide—prostate cancer	0.000253	0.000257	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—prostate cancer	0.000251	0.000255	CcSEcCtD
Perflutren—Malaise—Epirubicin—prostate cancer	0.00025	0.000254	CcSEcCtD
Perflutren—Fatigue—Prednisone—prostate cancer	0.00025	0.000253	CcSEcCtD
Perflutren—Vertigo—Epirubicin—prostate cancer	0.000249	0.000253	CcSEcCtD
Perflutren—Syncope—Epirubicin—prostate cancer	0.000249	0.000252	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—prostate cancer	0.000248	0.000252	CcSEcCtD
Perflutren—Back pain—Doxorubicin—prostate cancer	0.000248	0.000252	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—prostate cancer	0.000247	0.000251	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—prostate cancer	0.000247	0.00025	CcSEcCtD
Perflutren—Palpitations—Epirubicin—prostate cancer	0.000245	0.000249	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—prostate cancer	0.000244	0.000247	CcSEcCtD
Perflutren—Cough—Epirubicin—prostate cancer	0.000242	0.000246	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—prostate cancer	0.000242	0.000246	CcSEcCtD
Perflutren—Asthenia—Docetaxel—prostate cancer	0.000241	0.000244	CcSEcCtD
Perflutren—Convulsion—Epirubicin—prostate cancer	0.00024	0.000244	CcSEcCtD
Perflutren—Nausea—Etoposide—prostate cancer	0.00024	0.000243	CcSEcCtD
Perflutren—Hypertension—Epirubicin—prostate cancer	0.000239	0.000243	CcSEcCtD
Perflutren—Hypersensitivity—Capecitabine—prostate cancer	0.000239	0.000243	CcSEcCtD
Perflutren—Feeling abnormal—Prednisone—prostate cancer	0.000239	0.000242	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—prostate cancer	0.000238	0.000242	CcSEcCtD
Perflutren—Pruritus—Docetaxel—prostate cancer	0.000237	0.000241	CcSEcCtD
Perflutren—Gastrointestinal pain—Prednisone—prostate cancer	0.000237	0.00024	CcSEcCtD
Perflutren—Myalgia—Epirubicin—prostate cancer	0.000236	0.00024	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—prostate cancer	0.000236	0.00024	CcSEcCtD
Perflutren—Chest pain—Epirubicin—prostate cancer	0.000236	0.00024	CcSEcCtD
Perflutren—Agitation—Doxorubicin—prostate cancer	0.000236	0.000239	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000235	0.000238	CcSEcCtD
Perflutren—Discomfort—Epirubicin—prostate cancer	0.000233	0.000237	CcSEcCtD
Perflutren—Asthenia—Capecitabine—prostate cancer	0.000233	0.000237	CcSEcCtD
Perflutren—Malaise—Doxorubicin—prostate cancer	0.000231	0.000235	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—prostate cancer	0.000231	0.000234	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—prostate cancer	0.000231	0.000234	CcSEcCtD
Perflutren—Syncope—Doxorubicin—prostate cancer	0.00023	0.000234	CcSEcCtD
Perflutren—Urticaria—Prednisone—prostate cancer	0.00023	0.000233	CcSEcCtD
Perflutren—Pruritus—Capecitabine—prostate cancer	0.00023	0.000233	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—prostate cancer	0.00023	0.000233	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—prostate cancer	0.00023	0.000233	CcSEcCtD
Perflutren—Body temperature increased—Prednisone—prostate cancer	0.000229	0.000232	CcSEcCtD
Perflutren—Abdominal pain—Prednisone—prostate cancer	0.000229	0.000232	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—prostate cancer	0.000227	0.00023	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—prostate cancer	0.000226	0.00023	CcSEcCtD
Perflutren—Oedema—Epirubicin—prostate cancer	0.000226	0.00023	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—prostate cancer	0.000226	0.000229	CcSEcCtD
Perflutren—Cough—Doxorubicin—prostate cancer	0.000224	0.000227	CcSEcCtD
Perflutren—Shock—Epirubicin—prostate cancer	0.000223	0.000226	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—prostate cancer	0.000222	0.000226	CcSEcCtD
Perflutren—Diarrhoea—Capecitabine—prostate cancer	0.000222	0.000226	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—prostate cancer	0.000222	0.000225	CcSEcCtD
Perflutren—Dizziness—Docetaxel—prostate cancer	0.000222	0.000225	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—prostate cancer	0.000222	0.000225	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—prostate cancer	0.000221	0.000224	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—prostate cancer	0.00022	0.000223	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—prostate cancer	0.000219	0.000222	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—prostate cancer	0.000219	0.000222	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—prostate cancer	0.000219	0.000222	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—prostate cancer	0.000219	0.000222	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000217	0.00022	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—prostate cancer	0.000216	0.000219	CcSEcCtD
Perflutren—Dizziness—Capecitabine—prostate cancer	0.000215	0.000218	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—prostate cancer	0.000214	0.000217	CcSEcCtD
Perflutren—Vomiting—Docetaxel—prostate cancer	0.000213	0.000217	CcSEcCtD
Perflutren—Hypersensitivity—Prednisone—prostate cancer	0.000213	0.000216	CcSEcCtD
Perflutren—Rash—Docetaxel—prostate cancer	0.000212	0.000215	CcSEcCtD
Perflutren—Hypotension—Epirubicin—prostate cancer	0.000212	0.000215	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—prostate cancer	0.000211	0.000215	CcSEcCtD
Perflutren—Headache—Docetaxel—prostate cancer	0.00021	0.000213	CcSEcCtD
Perflutren—Oedema—Doxorubicin—prostate cancer	0.000209	0.000213	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—prostate cancer	0.000209	0.000213	CcSEcCtD
Perflutren—Asthenia—Prednisone—prostate cancer	0.000208	0.000211	CcSEcCtD
Perflutren—Vomiting—Capecitabine—prostate cancer	0.000207	0.00021	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000206	0.000209	CcSEcCtD
Perflutren—Shock—Doxorubicin—prostate cancer	0.000206	0.000209	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—prostate cancer	0.000205	0.000208	CcSEcCtD
Perflutren—Rash—Capecitabine—prostate cancer	0.000205	0.000208	CcSEcCtD
Perflutren—Pruritus—Prednisone—prostate cancer	0.000205	0.000208	CcSEcCtD
Perflutren—Dermatitis—Capecitabine—prostate cancer	0.000205	0.000208	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—prostate cancer	0.000204	0.000207	CcSEcCtD
Perflutren—Headache—Capecitabine—prostate cancer	0.000204	0.000207	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—prostate cancer	0.000203	0.000207	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—prostate cancer	0.000203	0.000206	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—prostate cancer	0.000203	0.000206	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—prostate cancer	0.000202	0.000205	CcSEcCtD
Perflutren—Nausea—Docetaxel—prostate cancer	0.000199	0.000202	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—prostate cancer	0.000199	0.000202	CcSEcCtD
Perflutren—Diarrhoea—Prednisone—prostate cancer	0.000198	0.000201	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—prostate cancer	0.000196	0.000199	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000195	0.000198	CcSEcCtD
Perflutren—Fatigue—Epirubicin—prostate cancer	0.000195	0.000198	CcSEcCtD
Perflutren—Pain—Epirubicin—prostate cancer	0.000194	0.000196	CcSEcCtD
Perflutren—Nausea—Capecitabine—prostate cancer	0.000193	0.000196	CcSEcCtD
Perflutren—Dizziness—Prednisone—prostate cancer	0.000191	0.000194	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000191	0.000194	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—prostate cancer	0.000188	0.000191	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—prostate cancer	0.000187	0.00019	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—prostate cancer	0.000187	0.000189	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—prostate cancer	0.000185	0.000188	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—prostate cancer	0.000184	0.000187	CcSEcCtD
Perflutren—Vomiting—Prednisone—prostate cancer	0.000184	0.000187	CcSEcCtD
Perflutren—Rash—Prednisone—prostate cancer	0.000183	0.000185	CcSEcCtD
Perflutren—Dermatitis—Prednisone—prostate cancer	0.000182	0.000185	CcSEcCtD
Perflutren—Headache—Prednisone—prostate cancer	0.000181	0.000184	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000181	0.000184	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—prostate cancer	0.000181	0.000183	CcSEcCtD
Perflutren—Urticaria—Epirubicin—prostate cancer	0.00018	0.000183	CcSEcCtD
Perflutren—Pain—Doxorubicin—prostate cancer	0.000179	0.000182	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—prostate cancer	0.000179	0.000182	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—prostate cancer	0.000179	0.000182	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—prostate cancer	0.000173	0.000175	CcSEcCtD
Perflutren—Nausea—Prednisone—prostate cancer	0.000172	0.000175	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000171	0.000174	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—prostate cancer	0.000167	0.000169	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—prostate cancer	0.000166	0.000169	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—prostate cancer	0.000166	0.000168	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—prostate cancer	0.000166	0.000168	CcSEcCtD
Perflutren—Asthenia—Epirubicin—prostate cancer	0.000162	0.000165	CcSEcCtD
Perflutren—Pruritus—Epirubicin—prostate cancer	0.00016	0.000163	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—prostate cancer	0.000155	0.000157	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—prostate cancer	0.000154	0.000157	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—prostate cancer	0.00015	0.000153	CcSEcCtD
Perflutren—Dizziness—Epirubicin—prostate cancer	0.00015	0.000152	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—prostate cancer	0.000148	0.00015	CcSEcCtD
Perflutren—Vomiting—Epirubicin—prostate cancer	0.000144	0.000146	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—prostate cancer	0.000143	0.000145	CcSEcCtD
Perflutren—Rash—Epirubicin—prostate cancer	0.000143	0.000145	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—prostate cancer	0.000143	0.000145	CcSEcCtD
Perflutren—Headache—Epirubicin—prostate cancer	0.000142	0.000144	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—prostate cancer	0.000139	0.000141	CcSEcCtD
Perflutren—Nausea—Epirubicin—prostate cancer	0.000134	0.000136	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—prostate cancer	0.000133	0.000135	CcSEcCtD
Perflutren—Rash—Doxorubicin—prostate cancer	0.000132	0.000134	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—prostate cancer	0.000132	0.000134	CcSEcCtD
Perflutren—Headache—Doxorubicin—prostate cancer	0.000131	0.000133	CcSEcCtD
Perflutren—Nausea—Doxorubicin—prostate cancer	0.000124	0.000126	CcSEcCtD
